Mercer Global Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.84M | Buy |
|
|||||
|
2025
Q2 | $1.21M | Buy |
|
|||||
|
2025
Q1 | $387K | Buy |
|
|||||
|
2024
Q4 | $393K | Sell |
|
|||||
|
2024
Q3 | $528K | Buy |
|
|||||
|
2024
Q2 | $583K | Buy |
|
|||||
|
2024
Q1 | $705K | Sell |
|
|||||
|
2023
Q4 | $691K | Buy |
|
|||||
|
2023
Q3 | $499K | Buy |
|
|||||
|
2023
Q2 | $595K | Sell |
|
|||||
|
2023
Q1 | $573K | Buy |
|
|||||
|
2022
Q4 | $503K | Buy |
|
|||||
|
2022
Q3 | $799K | Sell |
|
|||||
|
2022
Q2 | $800K | Sell |
|
|||||
|
2022
Q1 | $840K | Buy |
|
|||||
|
2021
Q4 | $370K | Buy |
|
|||||
|
2021
Q3 | $467K | Buy |
|
|||||
|
2021
Q2 | $537K | Buy |
|
|||||
|
2021
Q1 | $359K | Buy |
|
|||||
|
2020
Q4 | $393K | Buy |
|